Canaan general partners Julie Grant (L) and Nina Kjellson

Canaan rais­es an­oth­er $800M as it launch­es its next fund with an em­pha­sis on biotech

Long­time VC play­er Canaan Part­ners has an­nounced its newest fund and ex­pects to fun­nel a good por­tion of that mon­ey in­to biotech over the next few years.

The tech­nol­o­gy and life sci­ences firm said it’s brought in a fresh $800 mil­lion to fund ear­ly-stage in­vest­ing. This is Canaan’s 12th such fund and ties the amount it brought in back in June 2017, which it said at the time was a com­pa­ny record.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA